Pre-eclampsia and maternal health through the prism of low-income countries-Reference-Cited by-同舟云学术

Pre-eclampsia and maternal health through the prism of low-income countries

Published:2022-10-10 Issue:2 Volume:51 Page:261-268
ISSN:0300-5577
Container-title:Journal of Perinatal Medicine
language:en
Short-container-title:

Author:

Medjedovic Edin¹²^ORCID,Kurjak Asim³,Stanojević Milan⁴³,Begic Edin⁵⁶

Affiliation:

1. Clinic of Gynecology and Obstetrics , Clinical Center University of Sarajevo , Sarajevo , Bosnia and Herzegovina

2. Department of Gynecology , School of Medicine, Sarajevo School of Science and Technology , Sarajevo , Bosnia and Herzegovina

3. Department of Obstetrics and Gynecology , University Hospital “Sveti Duh” , Zagreb , Croatia

4. Neonatal Unit, Department of Obstetrics and Gynecology , Medical School University of Zagreb , Zagreb , Croatia

5. Department of Cardiology , General Hospital “Prim.Dr. Abdulah Nakas” , Sarajevo , Bosnia and Herzegovina

6. Department of Pharmacology , Sarajevo Medical School, Sarajevo School of Science and Technology , Sarajevo , Bosnia and Herzegovina

Abstract

Abstract Hypertensive syndrome in pregnancy complicates up to 15% of pregnancies, and preeclampsia (PE) occurs in about 3–10% of pregnant women. Inadequate prenatal care is associated with higher mortality from PE, possibly due to reduced monitoring, detection, and missed opportunities for early intervention. The imperative of the clinician’s work is to monitor the symptoms and clinical signs of PE, and stratification of patients in relation to the risk of PE is essential. PE represents a multisystem inflammatory response, and the consequences can be expected in all organs. The question of the effect of PE on long-term maternal health is raised. The aim of the paper is to present the effect of PE on the patient’s health through the prism of low-income countries.

Publisher

Walter de Gruyter GmbH

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.degruyter.com/document/doi/10.1515/jpm-2022-0437/pdf

Reference68 articles.

1. Medjedovic, E, Kurjak, A, Stanojevic, M, Salihagic-Kadic, A, Begic, E. Preeclampsia: still a disease of theories. Donald Sch J Ultrasound Obstet Gynecol 2022;16:138–47. https://doi.org/10.5005/jp-journals-10009-1922.

2. Fox, R, Kitt, J, Leeson, P, Aye, CYL, Lewandowski, AJ. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med 2019;8:1625. https://doi.org/10.3390/jcm8101625.

3. American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122–31. https://doi.org/10.1097/01.AOG.0000437382.03963.88.

4. Wallace, K, Harris, S, Addison, A, Bean, C. HELLP syndrome: pathophysiology and current therapies. Curr Pharmaceut Biotechnol 2018;19:816–26. https://doi.org/10.2174/1389201019666180712115215.

5. Phipps, EA, Thadhani, R, Benzing, T, Karumanchi, SA. Preeclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol 2019;15:275–89. https://doi.org/10.1038/s41581-019-0119-6.